Showing 1 - 13 results of 13 for search '"human liver"', query time: 0.07s Refine Results
  1. 1

    Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo by Nikolaou, N, Arvaniti, A, Appanna, N, Sharp, A, Hughes, B, Digweed, D, Whitaker, M, Ross, RJ, Arlt, W, Penning, T, Morris, K, George, S, Keevil, B, Hodson, L, Gathercole, L, Tomlinson, JW

    Published 2020
    “…Steroid 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates endogenous glucocorticoids and catalyses an important step in bile acid synthesis. …”
    Journal article
  2. 2
  3. 3
  4. 4
  5. 5

    AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. by Nikolaou, N, Gathercole, L, Marchand, L, Althari, S, Dempster, N, Green, C, Van De Bunt, M, McNeil, C, Arvaniti, A, Hughes, B, Sgromo, B, Gillies, R, Marschall, H, Penning, T, Ryan, J, Arlt, W, Hodson, L, Tomlinson, J

    Published 2019
    “…Steroid 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid hormones and catalyzes a fundamental step in bile acid synthesis.…”
    Journal article
  6. 6

    The isolation of primary hepatocytes from human tissue: optimising the use of small non-encapsulated liver resection surplus by Green, C, Charlton, C, Wang, L, Silva, M, Morten, K, Hodson, L

    Published 2017
    “…Therefore, the aim of this work was to develop an alternative method to isolate hepatocytes from non-encapsulated and small samples of human liver tissue. Healthy tissue from 44 human liver resections were graded for steatosis and tissue weights between 7.8 and 600 g were used for hepatocyte isolations. …”
    Journal article
  7. 7

    Unravelling the role of AKR1D1 in human hepatocytes by Nikolaou, N

    Published 2017
    “…Steroid 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid hormones and catalyses a fundamental step in bile acid synthesis. …”
    Thesis
  8. 8

    Hepatic fatty acid partitioning. by Hodson, L, Frayn, K

    Published 2011
    “…These studies highlight our lack of understanding of the regulation of metabolic partitioning of fatty acids within the human liver. SUMMARY: The regulation of hepatic fatty acid partitioning involves many factors; not least insulin. …”
    Journal article
  9. 9

    Hepatic fatty acid partitioning by Hodson, L, Frayn, K

    Published 2011
    “…These studies highlight our lack of understanding of the regulation of metabolic partitioning of fatty acids within the human liver. Summary: The regulation of hepatic fatty acid partitioning involves many factors; not least insulin. …”
    Journal article
  10. 10
  11. 11

    Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids by Luukkonen, PK, Nick, A, Hölttä-Vuori, M, Thiele, C, Isokuortti, E, Lallukka-Brück, S, Zhou, Y, Hakkarainen, A, Lundbom, N, Peltonen, M, Orho-Melander, M, Orešič, M, Hyötyläinen, T, Hodson, L, Ikonen, E, Yki-Järvinen, H

    Published 2019
    “…Polyunsaturated TGs were increased, while phosphatidylcholines (PCs) were decreased in the human liver in 148M homozygous individuals as compared with 148I homozygotes. …”
    Journal article
  12. 12

    Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism by Green, C, Pramfalk, C, Charlton, C, Gunn, P, Cornfield, T, Pavlides, M, Karpe, F, Hodson, L

    Published 2020
    “…In vitro studies, using a human liver cell-line were undertaken to gain insight into the intra-hepatocellular effects of omega-3 FAs.…”
    Journal article
  13. 13

    Defatting of donor transplant livers during normothermic perfusion - a randomised clinical trial: study protocol for the DeFat study by Abbas, SH, Ceresa, CDL, Hodson, L, Coussios, C, Kounali, D, Knight, S, Friend, P

    Published 2024
    “…We have recently tested defatting interventions during normothermic machine perfusion (NMP) in discarded steatotic human livers that were not transplanted. A combination of therapies including forskolin (NKH477) and L-carnitine to defat liver cells and lipoprotein apheresis filtration were investigated. …”
    Journal article